Fresh Hemp Foods Submits First Hemp Seed GRAS Notices To Satisfy FDA
Canadian firm Fresh Hemp Foods submitted separate GRAS notices for hemp seed, protein and oil FDA Office of Food Additives. In each notice, firm says each hemp seed format is derived from varieties of cannabis sativa L. with low THC content, known as industrial hemp, that hemp seeds do not produce THC and that THC present in dehulled hemp seed comes from contact between the seeds and cannabinoid-containing resins from other plant parts during growth, harvest and processing.
You may also be interested in...
US Wellness Market In 2019: Farm Bill Made Cultivating Cannabidiol Policy FDA's Main Course In Supplements
As HBW Insight looks back on notable US wellness market developments and events for the previous 12 months, we find that news in the CBD space from the FDA and the industry dominated the sector throughout 2019.
House Appropriations subcommittee with FDA oversight makes clear in questions for Commissioner Gottlieb they support allowing use of constituent ingredients from hemp and cannabis plants in food and dietary supplement products. Members also press for approving US firms' applications for pharmaceuticals with cannabis-derived active ingredients. Gottlieb announces working group will guide FDA decisions on potential CBD-use rulemaking.
BioMedican is ready to produce CBG, cannabigerol, and THC-V, tetrahydrocannabivarin, through biosynthesis and plans by the end of the year to start making CBN, cannabinol, and THC-A, tetrahydrocannabinolic-acid.